Galleri Moves Closer to FDA Decision as Evidence on Multi-Cancer Blood Testing Evolves
As reported on Becker's Hospital Review, an FDA advisory committee has backed Grail’s Galleri blood test, bringing the U.S. closer to potentially having its first FDA-approved multi-cancer detection test. But…
Continue Reading
Galleri Moves Closer to FDA Decision as Evidence on Multi-Cancer Blood Testing Evolves
